Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study | |
Xu, Rui-Hua; Li, Jin; Bai, Yuxian; Xu, Jianming; Liu, Tianshu; Shen, Lin; Wang, Liwei; Pan, Hongming; Cao, Junning; Zhang, Dongsheng | |
刊名 | JOURNAL OF HEMATOLOGY & ONCOLOGY |
2017 | |
卷号 | 10 |
关键词 | Fruquintinib Metastatic colorectal cancer Progression-free survival VEGFR |
ISSN号 | 1756-8722 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3614741 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Xu, Rui-Hua,Li, Jin,Bai, Yuxian,et al. Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study[J]. JOURNAL OF HEMATOLOGY & ONCOLOGY,2017,10. |
APA | Xu, Rui-Hua.,Li, Jin.,Bai, Yuxian.,Xu, Jianming.,Liu, Tianshu.,...&Su, Weiguo.(2017).Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study.JOURNAL OF HEMATOLOGY & ONCOLOGY,10. |
MLA | Xu, Rui-Hua,et al."Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study".JOURNAL OF HEMATOLOGY & ONCOLOGY 10(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论